A recent study reveals that patient-reported care experience declined significantly at hospitals acquired by private equity firms, highlighting the potential impact of private equity acquisitions on patient care.
Baloxavir probably reduced risk of hospital admission for high-risk patients and may reduce time to alleviation of symptoms, without increasing adverse events related to treatment in patients with nonsevere influenza," finds comprehensive network meta-analysis of 73 trials involving 34,332 participants.
FDA grants first-ever marketing authorization for ZYN nicotine pouches following a scientific review that showed lower health risks compared to traditional tobacco products and minimal youth usage.
NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.
New research challenges conventional wisdom as never-smokers with NSCLC present with more advanced disease but achieve median survival of 6.6 years versus 3.9 years in smokers, upending traditional prognostic assumptions.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Keros Therapeutics halts testing of experimental blood pressure treatment due to safety concerns during mid-stage trial, citing excess fluid build up around the heart in patients with pulmonary arterial hypertension.
The US Food and Drug Administration has introduced a proposal to cap nicotine levels in cigarettes, with the goal of curbing addiction, reducing smoking rates, and averting millions of tobacco-related deaths by 2100.